STAT (2/1, Chen) reported research “suggests that by analyzing cervical cells’ genomes, researchers might be able to find genetic signatures that predict the risk of ovarian, breast, and endometrial cancers and flag patients that should be screened more aggressively.” Investigators “examined samples from cervical smears of roughly 2,000 women” and then “used that data to train an algorithm to discover methylation signatures in the cervical cells that correlate with gynecological cancer risk.” The findings were published in two papers (here and here) in Nature Communications.
